Carl Franzblau

This inventor holds 10 USPTO granted patents. Top assignees: Boston University, 3M Innovative Properties Company. Active years: 1986-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carl Franzblau. Retrieved from https://idiyas.com/inventor/carl-franzblau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 257(Granted Patents)

Location History:

Newton, MA (US) (1986 - 1996)
Newton Highlands, MA (US) (1993 - 1996)

Company Filing History:

3M Innovative Properties Company

patents

Years Active: 1986-1996

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5536640 - Ligand/anti-ligand assays for adherent proteins (1996-07-16),

2. 5489300 - Surgical method for implanting a corneal implant (1996-02-06),

3. 5489261 - Hydrogels capable of supporting cell growth (1996-02-06),

4. 5354662 - Measuring tissue breakdown products in body fluids (1994-10-11),

5. 5262303 - Ligand/anti-ligand assays for adherent proteins (1993-11-16),

6. 5217903 - Measuring connective tissue breakdown products in body fluids (1993-06-08),

7. 5108428 - Corneal implants and manufacture and use thereof (1992-04-28),

8. 5106743 - Hydrogels capable of supporting cell growth (1992-04-21),

9. 5032131 - Prosthesis holding device (1991-07-16),

10. 4565784 - Hydrogels capable of supporting cell growth (1986-01-21),

Title: The Innovations of Carl Franzblau

Introduction

Carl Franzblau is a notable inventor based in Newton, MA (US), recognized for his contributions to the field of biochemistry and protein assays. With a total of 10 patents, he has made significant advancements in the detection and measurement of various proteins, which are crucial for medical research and diagnostics.

Latest Patents

Franzblau's latest patents include innovative methods for conducting ligand/anti-ligand assays for adherent proteins. This invention provides a means to detect and measure proteins such as serum amyloid A (SAA), apolipoprotein Al (apoAl), and various cytokines including IL-1 beta, IL-6, and TNF alpha. Another significant patent involves hydrogels capable of supporting cell growth, which outlines a method for growing anchorage-dependent cells using a substrate that includes a hydrogel formed from an aqueous solution gelled with a crosslinked polymer.

Career Highlights

Throughout his career, Carl Franzblau has worked with prestigious institutions such as Boston University and Minnesota Mining and Manufacturing Company, where he has contributed to various research projects and innovations. His work has had a lasting impact on the field of protein assays and cell growth technologies.

Collaborations

Franzblau has collaborated with esteemed colleagues, including John T Capecchi and Donald F Gibbons, further enhancing the scope and impact of his research.

Conclusion

Carl Franzblau's innovative work in the field of biochemistry has led to significant advancements in protein detection and cell growth technologies. His contributions continue to influence research and development in the medical and scientific communities.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]